Archive for the ‘Health Policy’ Category

The Absurdly Profitable Business of Prior Authorizations

March 15, 2024 — Prior authorizations are a driving force in the burnout of physicians, denial of medical care, and the profitability of health insurance and pharmacy benefit plans. By one estimate, healthcare providers spend $35 billion every year on chasing down prior authorizations so that their patients can receive the care they need – whether that is a […]

Scarcity, Greed, and Drug Pricing in an Election Year

March 10, 2024 — For many of us, it’s just too painful to think about. But a rerun of the 2020 presidential election is coming and drug pricing is likely to be a big talking point for both of the major candidates. President Biden is talking about corporate greed while former President Trump is talking about reviving an executive […]

Indication for Heart Health Marks a New Era in Obesity Treatment

March 9, 2024 — It’s official. FDA now says that semaglutide, in doses used to treat obesity, can prevent heart attacks, strokes, and deaths in persons with cardiovascular disease and overweight or obesity. This is nothing short of the dawn of a new era in obesity treatment. FDA Division Director John Sharretts said it clearly: “This patient population has […]

Obesity Care Week: Sneaky Stigma Stalks Us

March 8, 2024 — Today, we are putting a bow on Obesity Care Week by coming back to a root problem that gets in the way of reducing the harm of obesity – stigma. It causes psychological distress for the people living with this disease and leads them to avoid medical care. Explicit weight bias has become less acceptable […]

Obesity Care Week: New Roles for Old Tools of Care

March 7, 2024 — Obesity Care Week this year comes at a time when we have shiny new tools for treating obesity that are garnering a whole lot of attention. One would have be living under a rock not to have heard all the buzz about semaglutide, tirzepatide, and a host of other medicines coming soon for obesity. But […]

Obesity Care Week: Equity for a Treatable Chronic Disease

March 6, 2024 — One of the core principles Obesity Care Week is that this chronic disease is treatable. That’s becoming plain to see with emergence of advanced GLP-1 therapies. But equity in access to obesity care is practically non-existent. Prices for these medicines are high, supplies are low, and health plans make a sport of torturing people who […]

Obesity Care Week: Five Enduring Principles

March 5, 2024 — On this, the second day of Obesity Care Week, let’s step back from all the complexity of obesity and focus on five simple principles that hold great promise for improving the way we care for people with this disease. It really doesn’t have to be so hard. 1. It Is Undeniable That Obesity Is a […]

Pretending to Keep the Cost of Treating Obesity Down

March 4, 2024 — Today marks the start of Obesity Care Week and all over the globe, this is World Obesity Day. To mark this day, dozens of advocates from all of the major organizations that care about improving the standard of care for obesity have converged on the U.S. Capitol for dialog with policymakers about opening the pathway […]

Yogurt Gets an Ad Claim for Preventing Diabetes

March 3, 2024 — Five years ago, Danone asked FDA if it would be OK to say eating yogurt might prevent type 2 diabetes. Or to be precise, “eating yogurt regularly may reduce the risk of type 2 diabetes.” Friday, FDA told Danone, yep, we’re cool with that. Or, in the language of the agency: “FDA concludes that the […]

Making Sense of Ultra-Processed Research Clickbait

March 2, 2024 — Nutrition research in medical journals follows trends that define what the cognoscenti can regard healthy – or not. For decades, the bad stuff was fat. Then we switched to the sugar is toxic meme and that was the preoccupation through the 2010s. Now there can be no doubt. Research on ultra-processed foods is providing a steady […]